Tech Times of New York
SEE OTHER BRANDS

Hottest science and technology news from New York

Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

Press releases published on July 8, 2025

Genfit: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

Genfit: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), July 8, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today …

Genfit : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial

Genfit : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial

Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 8 juillet 2025 – GENFIT (Nasdaq et Euronext: GNFT), société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie pouvant engager …

BenchPrep Expands Learning Platform with Enhanced Continuing Education Capabilities

BenchPrep Expands Learning Platform with Enhanced Continuing Education Capabilities

CHICAGO, July 08, 2025 (GLOBE NEWSWIRE) -- BenchPrep, an award-winning learning management system, today announced the expansion of its platform to power Continuing Education (CE) programs. With enhanced capabilities, credentialing bodies and professional …

Adeia to Release Second Quarter 2025 Financial Results on August 5, 2025

Adeia to Release Second Quarter 2025 Financial Results on August 5, 2025

SAN JOSE, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- Adeia Inc. (Nasdaq: ADEA) will announce its financial results for the second quarter ended June 30, 2025, on Tuesday, August 5, 2025, following the close of market. The company will host an earnings …

Latham Group, Inc. Announces Second Quarter 2025 Earnings Release and Conference Call Date

Latham Group, Inc. Announces Second Quarter 2025 Earnings Release and Conference Call Date

LATHAM, N.Y., July 08, 2025 (GLOBE NEWSWIRE) -- Latham Group, Inc. (Nasdaq: SWIM), the largest designer, manufacturer, and marketer of in-ground residential swimming pools in North America, Australia, and New Zealand, today announced that it will release …

BrightSpring Health Services, Inc. to Announce Second Quarter 2025 Financial Results on August 1, 2025

BrightSpring Health Services, Inc. to Announce Second Quarter 2025 Financial Results on August 1, 2025

LOUISVILLE, Ky., July 08, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its second quarter 2025 financial results on Friday, August 1, 2025, prior to …

Rush Enterprises, Inc. Conference Call Advisory for Second Quarter 2025 Earnings Results

Rush Enterprises, Inc. Conference Call Advisory for Second Quarter 2025 Earnings Results

NEW BRAUNFELS, Texas, July 08, 2025 (GLOBE NEWSWIRE) -- Rush Enterprises, Inc., (NASDAQ: RUSHA …

Lamar Advertising Company to Release Second Quarter Ended June 30, 2025 Operating Results

Lamar Advertising Company to Release Second Quarter Ended June 30, 2025 Operating Results

BATON ROUGE, La., July 08, 2025 (GLOBE NEWSWIRE) -- Lamar Advertising Company (Nasdaq: LAMR) will release its second quarter ended June 30, 2025 earnings report before the market opens on Friday, August 8, 2025. Lamar will host a conference call on Friday, …

Solid Biosciences Announces FDA IND and Health Canada CTA Approval for First-in-Class Cardiac Gene Therapy to Treat Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

Solid Biosciences Announces FDA IND and Health Canada CTA Approval for First-in-Class Cardiac Gene Therapy to Treat Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

- SGT-501 is a novel gene therapy for rare, life-threatening, genetic arrhythmogenic disease with no approved therapies - - SGT-501 has received Orphan Drug Designation and Rare Pediatric Disease Designation from the FDA - - Solid expects to initiate Phase …

Astera Labs Announces Conference Call to Review Second Quarter 2025 Financial Results

Astera Labs Announces Conference Call to Review Second Quarter 2025 Financial Results

SANTA CLARA, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (Nasdaq: ALAB), a global leader in semiconductor-based connectivity solutions for AI and cloud infrastructure, today announced that it will release its financial results for the …

Indonesia’s Consumer Protection Agency and Elong Power Enter into Strategic Cooperation Agreement

Indonesia’s Consumer Protection Agency and Elong Power Enter into Strategic Cooperation Agreement

Beijing, China, July 08, 2025 (GLOBE NEWSWIRE) -- Elong Power Holding Limited (“Elong Power” or the “Company”) (Nasdaq: ELPW), a Nasdaq-listed company engaged in both high-power battery and energy storage system sectors, today announced that it has entered …

Nasdaq Reports June 2025 Volumes and 2Q25 Statistics

Nasdaq Reports June 2025 Volumes and 2Q25 Statistics

NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for June 2025, as well as quarterly volumes, estimated revenue capture, number of listings, and index statistics for the quarter ended June 30, 2025, on its …

Vertex to Announce Second Quarter 2025 Financial Results on Wednesday, August 6, 2025

Vertex to Announce Second Quarter 2025 Financial Results on Wednesday, August 6, 2025

KING OF PRUSSIA, Pa., July 08, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX), a leading global technology provider of indirect tax solutions, today announced that it will release second quarter 2025 financial results before the market opens on …

Lixte Biotechnology Holdings, Inc. Announces the Closing of $1.5 Million Registered Direct Offering

Lixte Biotechnology Holdings, Inc. Announces the Closing of $1.5 Million Registered Direct Offering

PASADENA, CALIF, July 08, 2025 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the “Company”), a clinical stage pharmaceutical company, today announced the closing of a registered direct offering with accredited investors for the …

MidCap Financial Investment Corporation Schedules Earnings Release and Conference Call for Quarter Ended June 30, 2025

MidCap Financial Investment Corporation Schedules Earnings Release and Conference Call for Quarter Ended June 30, 2025

NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- MidCap Financial Investment Corporation (NASDAQ: MFIC) (the “Company”) announced today that it will report results for the quarter ended June 30, 2025, after the closing of the Nasdaq Global Select Market on …

Rhythm Pharmaceuticals To Announce Topline Results from Phase 2 Trial Evaluating Oral MC4R Agonist Bivamelagon in Acquired Hypothalamic Obesity

Rhythm Pharmaceuticals To Announce Topline Results from Phase 2 Trial Evaluating Oral MC4R Agonist Bivamelagon in Acquired Hypothalamic Obesity

BOSTON, July 08, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced the Company …

Flywire to Announce Second Quarter 2025 Results on August 5, 2025

Flywire to Announce Second Quarter 2025 Results on August 5, 2025

BOSTON, July 08, 2025 (GLOBE NEWSWIRE) -- Today, Flywire Corporation (Flywire) (Nasdaq: FLYW), a global payments enablement and software company, announced that its second quarter financial results will be released after market close on Tuesday, August 5, …

AAPL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Apple Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

AAPL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Apple Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

PEPG INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that PepGen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

PEPG INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that PepGen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

TEM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

TEM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions